2-Thiohydantoin (BioDeep_00000788771)
代谢物信息卡片
2-Thiohydantoin
化学式: C3H4N2OS (116.0044334)
中文名称: 2-硫代乙内酰脲
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1C(=O)NC(=S)N1
InChI: InChI=1S/C3H4N2OS/c6-2-1-4-3(7)5-2/h1H2,(H2,4,5,6,7)
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Bruna Taciane da Silva Bortoleti, Manoela Daiele Gonçalves, Fernanda Tomiotto-Pellissier, Priscila Goes Camargo, João Paulo Assolini, Virginia Marcia Concato, Mariana Barbosa Detoni, Danielle Larazin Bidóia, Marcelle de Lima Ferreira Bispo, Camilo Henrique da Silva Lima, Fernando Cesar de Macedo, Ivete Conchon-Costa, Milena Menegazzo Miranda-Sapla, Pryscilla Fanini Wowk, Wander Rogério Pavanelli. Investigation of the antileishmanial activity and mechanisms of action of acetyl-thiohydantoins.
Chemico-biological interactions.
2022 Jan; 351(?):109690. doi:
10.1016/j.cbi.2021.109690. [PMID: 34637778] - Yue Gu, Mengxia Xue, Qizhi Wang, Xiaodan Hong, Xinyu Wang, Fang Zhou, Jianguo Sun, Guangji Wang, Ying Peng. Novel Strategy of Proxalutamide for the Treatment of Prostate Cancer through Coordinated Blockade of Lipogenesis and Androgen Receptor Axis.
International journal of molecular sciences.
2021 Dec; 22(24):. doi:
10.3390/ijms222413222. [PMID: 34948018] - Alex Yu, Maura Erba, Anasuya Hazra. Pharmacokinetics and Use-Testing of Apalutamide Prepared in Aqueous Food Vehicles for Alternative Administration.
Clinical pharmacology in drug development.
2021 11; 10(11):1375-1384. doi:
10.1002/cpdd.1001. [PMID: 34273257] - Huiping Li, Guohong Song, Qiaoxia Zhou, Ran Ran, Hanfang Jiang, Ruyan Zhang, Yaxin Liu, Jiayang Zhang, Luping Meng, Liandong Ma, Ye Sun, Meiyu Wang, Qingqing Zhou, Honghua Yan, Qianxiang Zhou, Xunwei Dong, Youzhi Tong. Activity of preclinical and phase I clinical trial of a novel androgen receptor antagonist GT0918 in metastatic breast cancer.
Breast cancer research and treatment.
2021 Oct; 189(3):725-736. doi:
10.1007/s10549-021-06345-x. [PMID: 34392453] - Qinglin Cheng, Junfang Chen, Qingjun Jia, Zijian Fang, Gang Zhao. Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials.
Aging.
2021 09; 13(18):21866-21902. doi:
10.18632/aging.203522. [PMID: 34531332] - Ranran Zhang, Junhong Liu, Hui Yan, Xingrong Peng, Ling Zhang, Minghua Qiu. Macathiohydantoin L, a Novel Thiohydantoin Bearing a Thioxohexahydroimidazo [1,5-a] Pyridine Moiety from Maca (Lepidium meyenii Walp.).
Molecules (Basel, Switzerland).
2021 Aug; 26(16):. doi:
10.3390/molecules26164934. [PMID: 34443522] - Mathieu Roumiguié, Xavier Paoletti, Yann Neuzillet, Romain Mathieu, Sebastien Vincendeau, François Kleinclauss, Arnaud Mejean, Laurent Guy, Marc Olivier Timsit, Thierry Lebret. Apalutamide, darolutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer: a meta-analysis.
Future oncology (London, England).
2021 May; 17(14):1811-1823. doi:
10.2217/fon-2020-1104. [PMID: 33543650] - Flavio Cadegiani, Erica M Lin, Andy Goren, Carlos G Wambier. Potential risk for developing severe COVID-19 disease among anabolic steroid users.
BMJ case reports.
2021 Feb; 14(2):. doi:
10.1136/bcr-2021-241572. [PMID: 33637513] - Hua Sang, Yu Wang, Yunxi Zhong, Shiyin Gu, Guangji Wang, Jianguo Sun, Ying Peng. Quantitative determination of proxalutamide in rat plasma and tissues using liquid chromatography/tandem mass spectrometry.
Rapid communications in mass spectrometry : RCM.
2021 Feb; 35(3):e9003. doi:
10.1002/rcm.9003. [PMID: 33169448] - Hiroji Uemura, Yosuke Koroki, Yuki Iwaki, Keiichiro Imanaka, Takeshi Kambara, Angela Lopez-Gitlitz, Andressa Smith, Hirotsugu Uemura. Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study.
BMC urology.
2020 Sep; 20(1):139. doi:
10.1186/s12894-020-00689-0. [PMID: 32878613] - An Van den Bergh, Jan Snoeys, Loeckie De Zwart, Peter Ward, Angela Lopez-Gitlitz, Daniele Ouellet, Mario Monshouwer, Caly Chien. Pharmacokinetic Drug-Drug Interaction of Apalutamide, Part 2: Investigating Interaction Potential Using a Physiologically Based Pharmacokinetic Model.
Clinical pharmacokinetics.
2020 09; 59(9):1149-1160. doi:
10.1007/s40262-020-00881-3. [PMID: 32338346] - Ignacio Duran, Joan Carles, Iurie Bulat, Peter Hellemans, Anna Mitselos, Peter Ward, James Jiao, Danielle Armas, Caly Chien. Pharmacokinetic Drug-Drug Interaction of Apalutamide, Part 1: Clinical Studies in Healthy Men and Patients with Castration-Resistant Prostate Cancer.
Clinical pharmacokinetics.
2020 09; 59(9):1135-1148. doi:
10.1007/s40262-020-00882-2. [PMID: 32338345] - Carlos Pérez-Ruixo, Jonás Samuel Pérez-Blanco, Caly Chien, Margaret Yu, Daniele Ouellet, Juan-José Pérez-Ruixo, Oliver Ackaert. Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects.
Clinical pharmacokinetics.
2020 02; 59(2):229-244. doi:
10.1007/s40262-019-00808-7. [PMID: 31432469] - Changhua Ji, Mausumee Guha, Xu Zhu, Jessica Whritenour, Michelle Hemkens, Susanna Tse, Gregory S Walker, Ellen Evans, Nasir K Khan, Martin B Finkelstein, Ernesto Callegari, R Scott Obach. Enzalutamide and Apalutamide: In Vitro Chemical Reactivity Studies and Activity in a Mouse Drug Allergy Model.
Chemical research in toxicology.
2020 01; 33(1):211-222. doi:
10.1021/acs.chemrestox.9b00247. [PMID: 31538772] - Tomohiro Tsuchiya, Keiichiro Imanaka, Yuki Iwaki, Ryo Oyama, Katsuyoshi Hashine, Akito Yamaguchi, Hiroji Uemura. An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer.
International journal of clinical oncology.
2019 Dec; 24(12):1596-1604. doi:
10.1007/s10147-019-01526-7. [PMID: 31446511] - Tae Hyun Lee, Zahra Khan, Sun Yeou Kim, Kang Ro Lee. Thiohydantoin and Hydantoin Derivatives from the Roots of Armoracia rusticana and Their Neurotrophic and Anti-neuroinflammatory Activities.
Journal of natural products.
2019 11; 82(11):3020-3024. doi:
10.1021/acs.jnatprod.9b00527. [PMID: 31625742] - Wenzhong Shi, Jingya Ruan, Yuanqiang Guo, Zhijuan Ding, Jiejing Yan, Lu Qu, Chang Zheng, Yi Zhang, Tao Wang. Bioactive constituents study of Pugionium cornutum L. Gaertn on intestinal motility.
Fitoterapia.
2019 Oct; 138(?):104291. doi:
10.1016/j.fitote.2019.104291. [PMID: 31401221] - Ronald de Vries, Frank Jacobs, Geert Mannens, Jan Snoeys, Filip Cuyckens, Caly Chien, Peter Ward. Apalutamide Absorption, Metabolism, and Excretion in Healthy Men, and Enzyme Reaction in Human Hepatocytes.
Drug metabolism and disposition: the biological fate of chemicals.
2019 05; 47(5):453-464. doi:
10.1124/dmd.118.084517. [PMID: 30787101] - Neil R Parikh, Claudia Huiza, Jill S Patel, Sonny Tsai, Nathisha Kalpage, May Thein, Sage Pitcher, Steve P Lee, Warren S Inouye, Mark L Jordan, Homayoon Sanati, Lida Jafari, Carol J Bennett, Greg E Gin, Amar U Kishan, Robert E Reiter, Michael Lewis, Ahmad Sadeghi, William J Aronson, Isla P Garraway, Matthew B Rettig, Nicholas G Nickols. Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease.
BMC cancer.
2019 Apr; 19(1):291. doi:
10.1186/s12885-019-5496-5. [PMID: 30935383] - Bodine P S I Belderbos, Ronald de Wit, Caly Chien, Anna Mitselos, Peter Hellemans, James Jiao, Margaret K Yu, Gerhardt Attard, Iurie Bulat, W Jeffrey Edenfield, Fred Saad. An open-label, multicenter, phase Ib study investigating the effect of apalutamide on ventricular repolarization in men with castration-resistant prostate cancer.
Cancer chemotherapy and pharmacology.
2018 09; 82(3):457-468. doi:
10.1007/s00280-018-3632-6. [PMID: 29974203] - Yuanqiong Huang, Zhonglin Guo, Hongjian Song, Yuxiu Liu, Lizhong Wang, Qingmin Wang. Design, Synthesis, and Biological Activity of β-Carboline Analogues Containing Hydantoin, Thiohydantoin, and Urea Moieties.
Journal of agricultural and food chemistry.
2018 Aug; 66(31):8253-8261. doi:
10.1021/acs.jafc.8b03087. [PMID: 30052037] - Gurulingappa Hallur, Buchi Reddy Purra, Suresh P Sulochana, Neeraj Kumar Saini, Prasanthi Daram, Mohd Zainuddin, Ramesh Mullangi. Validation of an LC-ESI-MS/MS method for the determination of apalutamide, a novel non-steroidal anti-androgen in mice plasma and its application to a pharmacokinetic study in mice.
Journal of pharmaceutical and biomedical analysis.
2018 May; 153(?):260-266. doi:
10.1016/j.jpba.2018.02.054. [PMID: 29518645] - Lorenzo Tosco, Annouschka Laenen, Thomas Gevaert, Isabelle Salmon, Christine Decaestecker, Elai Davicioni, Christine Buerki, Frank Claessens, Johan Swinnen, Karolien Goffin, Raymond Oyen, Wouter Everaerts, Lisa Moris, Gert De Meerleer, Karin Haustermans, Steven Joniau. Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial.
BMC cancer.
2018 04; 18(1):354. doi:
10.1186/s12885-018-4275-z. [PMID: 29606109] - Ksenia Tishchenko, Elena Beloglazkina, Mikhail Proskurnin, Vladislav Malinnikov, Dmitriy Guk, Marina Muratova, Olga Krasnovskaya, Anna Udina, Dmitry Skvortsov, Radik R Shafikov, Yan Ivanenkov, Vladimir Aladinskiy, Ivan Sorokin, Oleg Gromov, Alexander Majouga, Nikolay Zyk. New copper(II) thiohydantoin complexes: Synthesis, characterization, and assessment of their interaction with bovine serum albumin and DNA.
Journal of inorganic biochemistry.
2017 10; 175(?):190-197. doi:
10.1016/j.jinorgbio.2017.07.015. [PMID: 28756175] - Xuehai Pang, Yingwei Wang, Yuanwei Chen. Design, synthesis, and biological evaluation of deuterated apalutamide with improved pharmacokinetic profiles.
Bioorganic & medicinal chemistry letters.
2017 06; 27(12):2803-2806. doi:
10.1016/j.bmcl.2017.04.071. [PMID: 28478926] - Josephine F Trott, Jeffrey Kim, Omran Abu Aboud, Hiromi Wettersten, Benjamin Stewart, Grace Berryhill, Francisco Uzal, Russell C Hovey, Ching-Hsien Chen, Katie Anderson, Ashley Graef, Aaron L Sarver, Jaime F Modiano, Robert H Weiss. Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.
Oncotarget.
2016 10; 7(41):66540-66557. doi:
10.18632/oncotarget.11658. [PMID: 27572319] - Tatsuo Sugawara, Pascale Lejeune, Silke Köhr, Roland Neuhaus, Hortensia Faus, Kathy A Gelato, Matthias Busemann, Arwed Cleve, Ulrich Lücking, Franz von Nussbaum, Michael Brands, Dominik Mumberg, Klaus Jung, Carsten Stephan, Bernard Haendler. BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients.
Oncotarget.
2016 Feb; 7(5):6015-28. doi:
10.18632/oncotarget.6864. [PMID: 26760770] - Nobuyuki Ishikura, Hiromitsu Kawata, Ayako Nishimoto, Ryo Nakamura, Toshiaki Tsunenari, Miho Watanabe, Kazutaka Tachibana, Takuya Shiraishi, Hitoshi Yoshino, Akie Honma, Takashi Emura, Masateru Ohta, Toshito Nakagawa, Takao Houjo, Eva Corey, Robert L Vessella, Yuko Aoki, Haruhiko Sato. CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells.
International journal of oncology.
2015 Apr; 46(4):1560-72. doi:
10.3892/ijo.2015.2860. [PMID: 25634071] - Eva Gupta, Troy Guthrie, Winston Tan. Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC).
BMC urology.
2014 Jul; 14(?):55. doi:
10.1186/1471-2490-14-55. [PMID: 25062956] - James D Joseph, Nhin Lu, Jing Qian, John Sensintaffar, Gang Shao, Dan Brigham, Michael Moon, Edna Chow Maneval, Isan Chen, Beatrice Darimont, Jeffrey H Hager. A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509.
Cancer discovery.
2013 Sep; 3(9):1020-9. doi:
10.1158/2159-8290.cd-13-0226. [PMID: 23779130] - Dana Rathkopf, Howard I Scher. Androgen receptor antagonists in castration-resistant prostate cancer.
Cancer journal (Sudbury, Mass.).
2013 Jan; 19(1):43-9. doi:
10.1097/ppo.0b013e318282635a. [PMID: 23337756] - Massimo Del Bubba, Leonardo Checchini, Alessandra Cincinelli, Luciano Lepri. Enantioseparations by thin-layer chromatography.
Methods in molecular biology (Clifton, N.J.).
2013; 970(?):29-43. doi:
10.1007/978-1-62703-263-6_2. [PMID: 23283769] - Toshio Ishikawa, Hiroko Okinaga, Satoshi Takahashi, Maiko Numakura, Yamato Mashimo, Nakayuki Yoshimura, Tomomi Maeda, Daisuke Inoue, Ryo Okazaki, Makoto Kinoshita, J Larry Jameson, Tamio Teramoto. Serum from methimazole-treated patients induces activation of aryl hydrocarbon receptor, a transcription factor that binds to dioxin-response elements.
Thyroid : official journal of the American Thyroid Association.
2012 Aug; 22(8):769-77. doi:
10.1089/thy.2012.0057. [PMID: 22784254] - Nicola J Clegg, John Wongvipat, James D Joseph, Chris Tran, Samedy Ouk, Anna Dilhas, Yu Chen, Kate Grillot, Eric D Bischoff, Ling Cai, Anna Aparicio, Steven Dorow, Vivek Arora, Gang Shao, Jing Qian, Hong Zhao, Guangbin Yang, Chunyan Cao, John Sensintaffar, Teresa Wasielewska, Mark R Herbert, Celine Bonnefous, Beatrice Darimont, Howard I Scher, Peter Smith-Jones, Mark Klang, Nicholas D Smith, Elisa De Stanchina, Nian Wu, Ouathek Ouerfelli, Peter J Rix, Richard A Heyman, Michael E Jung, Charles L Sawyers, Jeffrey H Hager. ARN-509: a novel antiandrogen for prostate cancer treatment.
Cancer research.
2012 Mar; 72(6):1494-503. doi:
10.1158/0008-5472.can-11-3948. [PMID: 22266222] - Hiromitsu Kawata, Shinichi Arai, Toshito Nakagawa, Nobuyuki Ishikura, Ayako Nishimoto, Hitoshi Yoshino, Takuya Shiraishi, Kazutaka Tachibana, Ryo Nakamura, Haruhiko Sato. Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.
The Prostate.
2011 Sep; 71(12):1344-56. doi:
10.1002/pros.21351. [PMID: 21308717] - J Thanusu, V Kanagarajan, S Nagini, M Gopalakrishnan. Chemopreventive potential of 3-[2,6-bis(4-fluorophenyl)-3-methylpiperidin-4-ylideneamino]-2-thioxoimidazolidin-4-one on 7,12-dimethylbenz[a]anthracene (DMBA) induced hamster buccal pouch carcinogenesis.
Journal of enzyme inhibition and medicinal chemistry.
2010 Dec; 25(6):836-43. doi:
10.3109/14756361003724786. [PMID: 20370536] - Hassan Elokdah, Theodore S Sulkowski, Magid Abou-Gharbia, John A Butera, Sie-Yearl Chai, Geraldine R McFarlane, Mar-Lee McKean, John L Babiak, Steven J Adelman, Elaine M Quinet. Design, synthesis, and biological evaluation of thio-containing compounds with serum HDL-cholesterol-elevating properties.
Journal of medicinal chemistry.
2004 Jan; 47(3):681-95. doi:
10.1021/jm030219z. [PMID: 14736248] - K Kiec-Kononowicz, J Karolak-Wojciechowska, J Robak. Fused 2-thiohydantoin derivatives: evaluation as potential antioxidants.
Archiv der Pharmazie.
1997 Apr; 330(4):85-90. doi:
10.1002/ardp.19973300402. [PMID: 9230525] - J M Bailey, C G Miller. Automated methods for C-terminal protein sequencing.
Methods in molecular biology (Clifton, N.J.).
1997; 64(?):259-69. doi:
10.1385/0-89603-353-8:259. [PMID: 9116829] - G Bhalay, D Cowell, N D Hone, M Scobie, A D Baxter. Multiple solid-phase synthesis of hydantoins and thiohydantoins.
Molecular diversity.
1997 199; 3(3):195-8. doi:
10.1023/a:1009612923900. [PMID: 9680651] - H Gerber, G Huber, H J Peter, J Kämpf, T Lemarchand-Beraud, P Fragu, R Stocker. Transformation of normal thyroids into colloid goiters in rats and mice by diphenylthiohydantoin.
Endocrinology.
1994 Dec; 135(6):2688-99. doi:
10.1210/endo.135.6.7988459. [PMID: 7988459] - G G Skellern, B I Knight, F M Luman, J B Stenlake, D G McLarty, M J Hooper. Identification of 3-methyl-2-thiohydantoin, a metabolite of carbimazole, in man.
Xenobiotica; the fate of foreign compounds in biological systems.
1977 Apr; 7(4):247-53. doi:
10.3109/00498257709035782. [PMID: 868080] - D MARTIN, A RIECHE, R N IYER. [SYNTHETIC MUSTARD OIL CONSTITUENTS. IV. PREPARATION OF SUBSTITUTED THIOHYDANTOIC ACID, THIOHYDANTOIN AND RELATED COMPOUNDS AS POSSIBLE ANTIMICROBIAL ACTIVE AGENTS].
Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft.
1963 Oct; 296(?):641-50. doi:
10.1002/ardp.19632961002. [PMID: 14205482] - V I VEKSLER, M S REZNICHENKO, A A FREIMAN. [Determination of C-terminal groups of vegetable proteins by a thiohydantoin method].
Biokhimiia (Moscow, Russia).
1960 Jan; 25(?):124-8. doi:
". [PMID: 13841581] - E O THOMPSON. The N-terminal sequence of serum albumins; observations on the thiohydantoin method.
The Journal of biological chemistry.
1954 Jun; 208(2):565-72. doi:
10.1016/s0021-9258(18)65583-8. [PMID: 13174567]